Capital Fund Management (CFM)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
80,071
+7,737
| +11% | +$168K | ﹤0.01% | 650 |
|
|
2025
Q1 | $1.75M | Sell |
72,334
-51,122
| -41% | -$1.24M | 0.01% | 570 |
|
|
2024
Q4 | $2.58M | Sell |
123,456
-9,123
| -7% | -$190K | 0.01% | 530 |
|
|
2024
Q3 | $2.64M | Buy |
132,579
+6,492
| +5% | +$129K | 0.01% | 459 |
|
|
2024
Q2 | $1.95M | Sell |
126,087
-131,448
| -51% | -$2.04M | 0.01% | 498 |
|
|
2024
Q1 | $4.11M | Buy |
257,535
+6,316
| +3% | +$101K | 0.01% | 354 |
|
|
2023
Q4 | $4.22M | Sell |
251,219
-117,250
| -32% | -$1.97M | 0.01% | 379 |
|
|
2023
Q3 | $4.31M | Buy |
368,469
+44,063
| +14% | +$515K | 0.01% | 334 |
|
|
2023
Q2 | $4.36M | Buy |
324,406
+12,656
| +4% | +$170K | 0.02% | 297 |
|
|
2023
Q1 | $5.17M | Buy |
311,750
+197,016
| +172% | +$3.27M | 0.02% | 230 |
|
|
2022
Q4 | $2.13M | Buy |
114,734
+87,576
| +322% | +$1.63M | 0.01% | 344 |
|
|
2022
Q3 | $348K | Sell |
27,158
-33,668
| -55% | -$432K | ﹤0.01% | 522 |
|
|
2022
Q2 | $426K | Buy |
+60,826
| New | +$426K | ﹤0.01% | 563 |
|
|
2020
Q4 | – | Sell |
-144,063
| Closed | -$428K | – | 621 |
|
|
2020
Q3 | $428K | Buy |
144,063
+23,793
| +20% | +$70.7K | 0.01% | 498 |
|
|
2020
Q2 | $556K | Buy |
+120,270
| New | +$556K | 0.01% | 424 |
|
|
2020
Q1 | – | Sell |
-24,725
| Closed | -$93K | – | 915 |
|
|
2019
Q4 | $93K | Buy |
+24,725
| New | +$93K | ﹤0.01% | 858 |
|